PCA-derived factors that may be predictive of postoperative pain in pediatric patients: A possible role for the PCA ratio
DOI:
https://doi.org/10.5055/jom.2012.0094Keywords:
pain, patient-controlled analgesia, opioids, opioid rotationAbstract
Objective: No method exists to reliably predict which patients will develop severe postoperative pain. The authors hypothesized that data derived from patient-controlled analgesia (PCA) pumps (specifically the ratio of patient demands to pump deliveries) may predict which patients would develop severe pain after scoliosis repair.Setting: Quaternary, university-affiliated, pediatric hospital.
Patients and participants: Forty American Society of Anesthesiologists I-II pediatric patients who had undergone elective scoliosis repair and had consented to recruitment to a randomized clinical trial investigating the effects of early morphine administration on remifentanil-induced hyperalgesia.
Interventions: To test the hypothesis of the current study, the authors calculated the PCA ratio of demand to delivery at every 4 hours throughout the first 24 hours after surgery for all the patients recruited to the original study.
Main outcome measures: The authors compared calculated PCA ratios, numeric rating scale pain scores, and cumulative morphine consumption for those patients who developed severe postoperative pain and met the criteria for opioid rotation versus those patients who did not.
Results: Seven patients required opioid rotation from PCA morphine to PCA hydromorphone. Eight hours after surgery, the median PCA ratio for those seven patients (2.5 [range, 1.8-4.3]) was significantly greater than that for all other recruited patients (1.3 [range, 0-2.7]; p < 0.001).
Conclusions: Patients who developed severe postoperative pain and met the criteria for opioid rotation demonstrated significantly increased PCA ratios of demand to delivery as early as 8 hours after surgery.
References
Indelicato R, Portenoy R: Opioid rotation in the management of refractory cancer pain. J Clin Oncol. 2002; 20: 348-352.
Mercadante S, Portenoy R: Opioid poorly-responsive cancer pain, Part 1: Clinical considerations. J Pain Symptom Manage. 2001; 21: 144-150.
Mc Donnell C, Zaarour C, Hull R, et al.: Pre-treatment with morphine does not prevent the development of remifentanilinduced hyperalgesia. Can J Anesth. 2008; 55: 813-818.
Crawford M, Hickey C, Zaarour C, et al.: Development of acute opioid tolerance during infusion of remifentanil for pediatric scoliosis surgery. Anesth Analg. 2006; 102: 662-667.
Logan D, Rose J: Is postoperative pain a self-fulfilling prophecy? Expectancy effects on postoperative pain and patient-controlled analgesia use among adolescent surgical patients. J Pediatr Psychol. 2005; 30(2): 187-196.
Ginsberg B, Gil K, Muir M, et al.: The influence of lockout intervals and drug selection on patient-controlled analgesia following gynecological surgery. Pain. 1995; 62(1): 95-100.
de Stoutz N, Bruera E, Suarez-Almazor M: Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage. 1995; 10: 378-384.
Kloke M, Rapp M, Bosse B, et al.: Toxicity and/or insufficient analgesia by opioid therapy: Risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single centre. Support Care Cancer. 2000; 8: 479-486.
Farragi D, Reiser B: Estimation of the area under the ROC curve. Stat Med. 2002; 21: 3093-3106.
Published
How to Cite
Issue
Section
License
Copyright 2005-2024, Weston Medical Publishing, LLC
All Rights Reserved